Dr. Salama obtained his DDS and MD degrees from the University of Maryland School of Dental Medicine and School of Medicine respectively. He completed his OMFS training at the University of Maryland in 2005, and joined the faculty at the University of Maryland Medical Center following the completion of a Fellowship in Oral and Maxillofacial Oncology and Reconstruction in 2007. His primary clinical interests include treatment of head and neck malignancies and tumors, microvascular reconstruction and surgical management of craniofacial trauma.
He has a commitment to teaching on many levels and is the current residency program director at the Henry M. Goldman School of Dental Medicine. His current clinical research involves evaluating bone healing following reconstruction of the mandible with microvascular free tissue transfer and SEER based outcomes for head and neck cancer. He has published extensively in the peer-reviewed literature and has written several textbook chapters. He has traveled nationally and internationally to present abstracts and research.
- Assistant Professor, Otolaryngology-Head & Neck Surgery, Boston University School of Medicine
- Active Staff Privileges, Surgery, Boston Medical Center
- University of Maryland, MD
- Union College, BS
- University of Maryland, DDS
- University of Maryland, CAGS-Certificate of Advanced Graduate St
- Published on 6/1/2018
Rubin SJ, Gurary EB, Qureshi MM, Salama AR, Ezzat WH, Jalisi S, Truong MT. Stage II Oral Tongue Cancer: Survival Impact of Adjuvant Radiation Based on Depth of Invasion. Otolaryngol Head Neck Surg. 2018 Jun 01; 194599818779907. PMID: 29944460.
- Published on 2/8/2018
Kirke DN, Qureshi MM, Kamran SC, Ezzat W, Jalisi S, Salama A, Everett PC, Truong MT. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis. Head Neck. 2018 Jun; 40(6):1174-1184. PMID: 29417687.
- Published on 10/8/2017
Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT. Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope. 2018 Jun; 128(6):1353-1364. PMID: 28988426.
- Published on 9/19/2017
Rubin SJ, Kirke DN, Ezzat WH, Truong MT, Salama AR, Jalisi S. Marital status as a predictor of survival in patients with human papilloma virus-positive oropharyngeal cancer. Am J Otolaryngol. 2017 Nov - Dec; 38(6):654-659. PMID: 28947344.
- Published on 9/1/2017
Pynnonen MA, Gillespie MB, Roman B, Rosenfeld RM, Tunkel DE, Bontempo L, Brook I, Chick DA, Colandrea M, Finestone SA, Fowler JC, Griffith CC, Henson Z, Levine C, Mehta V, Salama A, Scharpf J, Shatzkes DR, Stern WB, Youngerman JS, Corrigan MD. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol Head Neck Surg. 2017 Sep; 157(2_suppl):S1-S30. PMID: 28891406.
- Published on 8/21/2017
Giacalone NJ, Qureshi MM, Mak KS, Kirke D, Patel SA, Shah BA, Salama AR, Jalisi S, Truong MT. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer. Laryngoscope. 2018 Apr; 128(4):831-840. PMID: 28833217.
- Published on 8/1/2017
Shapiro M, Salama A. Margin Analysis: Squamous Cell Carcinoma of the Oral Cavity. Oral Maxillofac Surg Clin North Am. 2017 Aug; 29(3):259-267. PMID: 28709529.
- Published on 7/27/2017
Alsaqer SF, Tashkandi MM, Kartha VK, Yang YT, Alkheriji Y, Salama A, Varelas X, Kukuruzinska M, Monti S, Bais MV. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget. 2017 Sep 26; 8(43):73372-73386. PMID: 29088714.
- Published on 5/8/2017
Dean J, Shapiro MC, Salama AR. In Reply: The Only Thing We Have to Blame Is Blame Itself. J Oral Maxillofac Surg. 2017 Aug; 75(8):1575-1576. PMID: 28495407.
- Published on 8/31/2016
Shapiro MC, Rao SR, Dean J, Salama AR. What a Shame: Increased Rates of OMS Resident Burnout May Be Related to the Frequency of Shamed Events During Training. J Oral Maxillofac Surg. 2017 Mar; 75(3):449-457. PMID: 27669370.
View 29 more publications: View full profile at BUMC